Use of gabapentinoids (gabapentin, pregabalin) by people with chronic obstructive pulmonary disease (COPD) was associated with a 39% increased risk for severe disease exacerbation, according to investigators from McGill University and Lady Davis Institute for Medial Research in Montreal, Canada. Findings from the population cohort study, published in the Annals of Internal Medicine, are the Gabapentinoid use was associated with severe exacerbation among users with COPD, supporting warnings from regulatory agencies about potentially serious adverse effects of the drugs, according to Though gabapentin has many potential uses, it can cause side effects. Read more about 13 gabapentin side effects here. Gabapentinoids are associated with an increased risk of severe exacerbation in people with chronic obstructive pulmonary disease (COPD), a study of more than 10 000 people has reported.1 Researchers from McGill University and Lady Davis Institute for Medical Research studied Canadian insurance data and found that the highest risk for severe COPD exacerbation occurred after around six months of In patients with COPD, gabapentinoid use was associated with increased risk for severe exacerbation. These findings support the warnings from regulatory agencies and highlight the importance of considering this potential risk when prescribing gabapentin and pregabalin to patients with COPD. A population-based cohort study of more than 10,000 persons using gabapentinoids found that their use was associated with an increased risk of chronic obstructive pulmonary disease (COPD) exacerbation. This study, published in Annals of Internal Medicine, supports the warnings from regulatory agencies and highlights the importance of considering this potential risk when prescribing gabapentin A population-based cohort study of more than 10,000 persons using gabapentinoids found that their use was associated with an increased risk of chronic obstructive pulmonary disease (COPD) exacerbation. This study supports the warnings from regulatory agencies and highlights the importance of considering this potential risk when prescribing gabapentin and pregabalin to patients with COPD. The The FDA has warned about gabapentin use in people with certain lung conditions. Learn how it may affect you. Gabapentin and pregabalin, commonly known as gabapentinoids, have been widely used globally. This paper highlights the serious breathing problems due to using gabapentin and pregabalin which was warned by the United States Food and Drug Conclusion: In patients with COPD, gabapentinoid use was associated with increased risk for severe exacerbation. This study supports the warnings from regulatory agencies and highlights the importance of considering this potential risk when prescribing gabapentin and pregabalin to patients with COPD. “In patients with COPD, gabapentinoid use was associated with increased risk for severe exacerbation,” the authors wrote. “This study supports the warnings from regulatory agencies and highlights the importance of considering this potential risk when prescribing gabapentin and pregabalin to patients with COPD.” FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) FDA Drug Safety Podcast Gabapentin, a medication primarily used to treat nerve pain and seizures, has garnered attention for its various side effects. Among the concerns of patients and healthcare providers alike is the potential for respiratory issues, specifically shortness of breath. Understanding whether Gabapentin causes shortness of breath requires a closer look at its pharmacological profile, common side Gabapentin is approved to prevent and control partial seizures, relieve postherpetic neuralgia after shingles and moderate-to-severe restless legs syndrome. Learn what side effects to watch for, drugs to avoid while taking gabapentin, how to take gabapentin and other important questions and answers. Gabapentin is available in both branded and generic forms. Gabapentin is an anticonvulsant medication prescribed for a variety of conditions. Learn about its uses, side effects, and what you should know if you've been prescribed this medication. Gabapentinoid use is associated with an increased risk for severe exacerbation among patients with chronic obstructive pulmonary disease. A European review of gabapentin was initiated due to reports of patients developing respiratory depression without concomitant opioid use. Animal studies suggest that gabapentinoids have an independent dose-dependent depressive effect on respiration and can augment respiratory function. The revised version highlights two high-risk population categories for developing gabapentinoids-induced Informing Practice January 25, 2024 Gabapentin and Pregabalin Are Associated with Severe COPD Exacerbations Daniel D. Dressler, MD, MSc, MHM, FACP, reviewing Rahman AA et al. Ann Intern Med 2024 Jan 16 A study suggests yet another potential adverse effect of gabapentinoid drugs. A population-based study showed increased exacerbations in patients with COPD across multiple gabapentinoid indications. Gabapentinoid use, namely gabapentin and pregabalin, was associated with increased risk for severe chronic obstructive pulmonary disease (COPD) exacerbation in patients with epilepsy, neuropathic
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |